6533b858fe1ef96bd12b61c6
RESEARCH PRODUCT
The disruption of myofibre structures in skeletal muscle after forced lengthening contractions
R. KalliokoskiHarm KuipersMatthijs K. C. HesselinkJ. Komulainensubject
Pathologymedicine.medical_specialtyNecrosisSkeletal muscleAnatomyBiologyPathology and Forensic Medicinemedicine.anatomical_structurePhysiology (medical)medicinebiology.proteinDesminmedicine.symptomMyofibrilIntermediate filamentDystrophinCytoskeletonActindescription
Specific antibodies against structural proteins (actin, desmin, dystrophin, fibronectin) of muscle fibres were used to study the effect of forced lengthening contractions on muscle microarchitecture. Tibialis anterior (TA) muscle of male Wistar rats were subjected to 240 forced lengthening contractions. At consecutive time points (0, and 6 h, 2, 4, and 7 days) after stimulation, the TA muscle was excised for biochemical and histological assays. β-Glucuronidase activity, a quantitative indicator of muscle damage, showed increased values 2–7 days after the lengthening, peaking on day 4 (11.7-fold increase). A typical course of histopathological changes (myofibre swelling, necrosis and regeneration) was observed. In immunohistochemistry, the earliest abnormality observed was discontinuous dystrophin staining in some swollen fibres immediately after commencement of exercise, while at the same time no alterations occurred in the staining of the other antibodies studied. Six hours later, all the swollen fibres were uniformly desmin as well as dystrophin negative. The great majority, but not all, of the swollen fibres showed disorganized actin staining and intramyocellular localization of fibronectin. The early phase disruption of myofibre structures as measured in this study provides evidence of their central role following damage in skeletal muscle. These results suggest that the sequence of structural changes in the route to muscle fibre necrosis in injury induced by forced lengthening contraction originates in the disruption of the plasma membrane and the intermediate filament, which leads to disturbances in the myofibrillar system.
year | journal | country | edition | language |
---|---|---|---|---|
1998-06-01 | Pathophysiology |